Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 76 out of 492
4918 citations found

CEST MRI and MALDI imaging reveal metabolic alterations in the cervical lymph nodes of EAE mice

Thomas, AM;Yang, E;Smith, MD;Chu, C;Calabresi, PA;Glunde, K;van Zijl, PCM;Bulte, JWM;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • EAE induction

    All animal studies are approved by the Johns Hopkins University Animal Care and Use Committee. Animals received standard husbandry. C57Bl/6 mice (female, 6–10 weeks, Jackson Laboratories, n = 5–8) were injected s.c. with 200 μl of emulsion containing incomplete Freund’s adjuvant (Sigma F5506) Mycobacterium tuberculosis H37Ra (Difco BD 231141, 5 mg/ml) and myelin oligodendrocyte glycopeptide (MOG35-55, Johns Hopkins Synthesis and Sequencing Facility, 0.5 mg/ml). Mice were injected i.p. with 100 μl of pertussis toxin (List Laboratories #180, 300 ng) on the day of induction and 2 days later. …

    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy

You, R;Artichoker, J;Ray, A;Gonzalez Velozo, H;Rock, DA;Conner, KP;Krummel, MF;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Macrophages disseminate pathogen associated molecular patterns through the direct extracellular release of the soluble content of their phagolysosomes

Greene, CJ;Nguyen, JA;Cheung, SM;Arnold, CR;Balce, DR;Wang, YT;Soderholm, A;McKenna, N;Aggarwal, D;Campden, RI;Ewanchuk, BW;Virgin, HW;Yates, RM;

Product: ULTRA PURE LPS from Salmonella minnesota R595 (Re)

  • … For imaging, cells were seeded in 96 well μClear® plates (Greiner Bio-One) or NuncTM MicroWellTM optical bottom 96-well plates (Thermo Fisher Scientific) and allowed to establish a confluent monolayer 16–24 h prior to evaluation by high content or scanning confocal microscopy, respectively. For immunofluorescence analysis, cells were seeded on a 12-mm microscope cover glass (VWR) in a 24-well plate overnight. Where indicated, BMMØs were cultured in the presence of either 10 ng/mL recombinant murine IL-4 or 100 U/mL recombinant murine IFN-γ (PeproTech) for 24 and 18 h respectively, prior to phagosomal assessment. Where indicated, cells were pulsed overnight with 2 mg/mL Bella Fluor (BF) 350SE-labelled (Setareh Biotech) dextran (70 kDa) with the dextran being chased into lysosomes the following day for 2 h. Where indicated, 2.5 mM of LLOMe was added to cells 30 min after phagocytosis of experimental particles and incubated for 2 h prior to imaging. Where indicated, 10 nM of myricetin (Alfa Aesar), 10 nM of kaempherol (Selleckchem) or 100 nM of EACC (Life Chemicals) were added to cells at the same time as experimental particles. Where indicated 0.5 μM Torin 1 (Tocris Bioscience), 0.5 μM rapamycin (Sigma Aldrich), 1× MEM amino acid solution (Sigma Aldrich), 10 ng/mL ultrapure lipopolysaccharide from S. Minnesota R595 (LPS; List Biologicals) were added to assay medium 30 min after the addition of reporter particles or 50 nM Lysotracker® Red (Invitrogen) 2 h after the addition of experimental particles and remained in the assay medium for the duration of phagosomal assessment.

    Product #434 – ULTRA PURE LPS from Salmonella minnesota R595 (Re)

Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia

Garcia-Bermudez, J;Badgley, MA;Prasad, S;Baudrier, L;Liu, Y;La, K;Soula, M;Williams, RT;Yamaguchi, N;Hwang, RF;Taylor, LJ;de Stanchina, E;Rostandy, B;Alwaseem, H;Molina, H;Bar-Sagi, D;Birsoy, K;

Product: LPS from Salmonella typhimurium

Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides

Nishi, R;Ohyagi, M;Nagata, T;Mabuchi, Y;Yokota, T;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination

Dowling, D;Barman, S;Smith, A;Borriello, F;Chaney, D;Brightman, S;Malhem, G;Brook, B;Menon, M;Soni, D;Schüller, S;Siram, K;Nanishi, E;Bazin, H;Burkhart, D;Levy, O;Evans, J;

Product: Pertactin from B. pertussis (69 kDa Protein)

  • … For anti-filamentous hemagglutinin (FHA) or anti-pertactin (PRN) ELISAs, CoStar 96 well high-binding
    plates (Corning, Corning, NY) were coated with either 2 µg/ml FHA (BP-FHA-100, The Native Antigen
    Company/Cedarlane, Burlington, NC) or 1 µg/ml PRN (B. pertussis Pertactin, Strain: B. pertussis strain
    165, The List Labs
    , St Campbell, CA) in carbonate buffer pH 9.6, incubated overnight at 4°C, washed 3x
    with wash buffer (KPL 10X Phosphate Buffered Saline with 0.05% Tween 20 (Fisher Scientific)) and
    blocked with Superblock (ScyTek) for 1 h at room temperature (RT). …

    Product #187 – Pertactin from B. pertussis (69 kDa Protein)

Monoclonal antibody on-rate constant determined from time-course data of ligand binding by capture ELISA: Evaluation of eight data analysis methods

Moreno, I;Infantes, JA;Domínguez, M;Toraño, A;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

NLRP3 licenses NLRP11 for inflammasome activation in human macrophages

Gangopadhyay, A;Devi, S;Tenguria, S;Carriere, J;Nguyen, H;Jäger, E;Khatri, H;Chu, LH;Ratsimandresy, RA;Dorfleutner, A;Stehlik, C;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • Cell culture

    … Where indicated, cells were also treated with nigericin (5 μM, Invivogen, 10–45 min), CTB (20 μg ml−1, List Biological Laboratories, 6 h), silica (200 μg ml−1, Invivogen, 6 h), TcdB (10 μg ml−1, R&D Systems, 8 h) and ATP (5 mM, Millipore-Sigma, 25 min); cultured in K+-free medium (0.8 mM MgCl2, 1.5 mM CaCl2, 10 mM HEPES, 5 mM glucose and 140 mM NaCl, pH 7.2, 3 h)50; or transfected with flagellin (500 ng ml−1, Invivogen, 4 h), poly(dA:dT) (1 μg ml−1, Invivogen, 4 h) or FSL-1 (0.2 μg ml−1, Invivogen, 4 h) and ultrapure LPS (1 μg ml−1, 4 h) with Lipofectamine 2000 (Invitrogen) or as otherwise indicated.

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

A vaccine targeting resistant tumours by dual T cell plus NK cell attack

Badrinath, S;Dellacherie, MO;Li, A;Zheng, S;Zhang, X;Sobral, M;Pyrdol, JW;Smith, KL;Lu, Y;Haag, S;Ijaz, H;Connor-Stroud, F;Kaisho, T;Dranoff, G;Yuan, GC;Mooney, DJ;Wucherpfennig, KW;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae